Home2B4 • FRA
Follow
Bonesupport Holding AB
Previous close
€20.74
Day range
€20.16 - €20.32
Year range
€7.77 - €21.62
Market cap
15.85B SEK
Avg Volume
24.00
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 172.74M | 67.35% |
Operating expense | 154.88M | 42.35% |
Net income | 10.73M | 152.27% |
Net profit margin | 6.21 | 131.21% |
Earnings per share | — | — |
EBITDA | 4.04M | 128.71% |
Effective tax rate | 419.56% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 167.35M | -16.86% |
Total assets | 688.82M | 85.26% |
Total liabilities | 143.64M | 39.60% |
Total equity | 545.18M | — |
Shares outstanding | 65.06M | — |
Price to book | 2.47 | — |
Return on assets | 1.41% | — |
Return on capital | 1.68% | — |
Cash Flow
Net change in cash
| (SEK) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 10.73M | 152.27% |
Cash from operations | 12.81M | 324.46% |
Cash from investing | -4.03M | -192.87% |
Cash from financing | -1.36M | 60.01% |
Net change in cash | 3.30M | 129.20% |
Free cash flow | 18.89M | 765.53% |
About
BoneSupport AB is a Swedish biotech company active at the Ideon Science Park in the university town of Lund in Skåne, Sweden, founded in 1999 by Lars Lidgren, Professor of Orthopedic Surgery and Academic Head of Department at Lund University Hospital in Sweden which is a member of the ISOC group of orthopaedic centers. The company has been funded with more than SEK 500 million in venture capital from inter alia HealthCap, Lundbeck foundation and Industrifonden, making it one of the largest ventures in the Swedish medical technologies industry. Wikipedia
Founded
1999
Website
Employees
110
